View in EDS

Managing drug–drug interactions in an HIV-infected patient receiving antiretrovirals, anti-HCV therapy and carbamazepine: A ‘tour de force’ for clinical pharmacologists.

Saved in:
Bibliographic Details
Title: Managing drug–drug interactions in an HIV-infected patient receiving antiretrovirals, anti-HCV therapy and carbamazepine: A ‘tour de force’ for clinical pharmacologists.
Authors: Burger, David M.1 David.Burger@radboudumc.nl, Arends, Joop E.2, Jacobs, Birgit S.1, van Elst-Laurijsen, Danielle H.M.2, de Kanter, Clara T.M.M.1, van Maarseveen, Erik M.3, Verwey-van Wissen, Corrien P.W.G.M.1, Hoepelman, Andy I.M.2
Source: International Journal of Antimicrobial Agents. Jul2014, Vol. 44 Issue 1, p86-88. 3p.
Database: Environment Complete
Description
ISSN:09248579
DOI:10.1016/j.ijantimicag.2014.04.004